Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Adenoid Cystic × Lutetium-177 × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 8 Urogenital Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Diseases 1 Prostate Cancer Metastatic 1 Pheochromocytoma 1 Paraganglioma 1 Oligometastatic Prostate Cancer (OMPC) 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Metastatic Neuroendocrine Prostate Cancer 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Metastatic Castration-Resistant Prostate Cancer 1 Metastatic Castration Resistant Prostate Cancer (mCRPC) 1 Lung Neoplasms 1 Gastro-enteropancreatic neuroendocrine tumor 1 Digestive System Neoplasms 1 Breast Neoplasms 1 Biochemically Recurrent Prostate Carcinoma 1

Interventions

pembrolizumab 4 Magnetic Resonance Spectroscopy 3 lenvatinib 2 Specimen Handling 2 Nivolumab 2 Carboplatin 2 regorafenib 1 gallium 68 PSMA-11 1 enfortumab vedotin 1 amivantamab 1 Tablets 1 Surveys and Questionnaires 1 Standard of Care 1 Radiosurgery 1 Pemetrexed 1 Ipilimumab 1 Imatinib Mesylate 1 Glutamate Carboxypeptidase II 1 Etoposide 1 Epirubicin 1 Endoscopic Mucosal Resection 1 Cyclophosphamide 1 Combined Modality Therapy 1 Cisplatin 1 CTLA-4 Antigen 1 Blood Specimen Collection 1 BMS-906024 1 68Ga-DKFZ-PSMA-11 1 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡